Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants

Pediatric Research

Volumn 77, Issue 3, 2015, Pages 477-483

  Sampath, Venkatesh ^a   Garland, Jeffery S ^b   Helbling, Daniel ^a   Dimmock, David ^a   Mulrooney, Neil P ^c   Simpson, Pippa M ^d   Murray, Jeffrey C ^e   Dagle, John M ^e  

^a Children's Hospital and Health System   (United States)

^b Wheaton Franciscan Healthcare   (United States)

^c CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^d Children's Hospital of Wisconsin   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTAMATE CYSTEINE LIGASE; GLUTAMATE CYSTEINE LIGASE CATALYTIC SUBUNIT; GLUTATHIONE TRANSFERASE P1; HEME OXYGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; STEROID; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, HUMAN;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CHORIOAMNIONITIS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; GENE EXPRESSION; GENE PROBE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID THERAPY; VERY LOW BIRTH WEIGHT; BIOLOGICAL MODEL; ENZYME INDUCTION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NEWBORN;

ANTIOXIDANT RESPONSE ELEMENTS; BRONCHOPULMONARY DYSPLASIA; ENZYME INDUCTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MODELS, GENETIC; NF-E2-RELATED FACTOR 2;

EID: 84938539815     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.200     Document Type: Article

References (40)

1. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and defnition. Semin Neonatol 2003;8:63-71.
2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
3. Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dyspla-sia. J Perinat Med 2010;38:571-7.
4. Asikainen TM, Raivio KO, Saksela M, Kinnula VL. Expression and developmental profle of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 1998;19:942-9.
5. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, infammation, and chronic lung disease. Pediatrics 2009;124:e439-49.
6. Joung KE, Kim HS, Lee J, et al. Correlation of urinary infammatory and oxida-tive stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia. Free Radic Res 2011;45:1024-32.
7. Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies. Neonatology 2014;105:55-63.
8. Bhandari V, Bizzarro MJ, Shetty A, et al.; Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006;117:1901-6.
9. Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 2013;132: 290-7.
10. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defned according to the consensus statement of the national institutes of health. Pediatrics 2008;122:479-85.
11. Asikainen TM, White C W. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 2004;6:155-67.
12. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 2006;8:76-87.
13. Tian H, Zhang B, Di J, et al. Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL. Cancer Lett 2012;325:26-34.
14. Cho HY, Kleeberger SR. Genetic mechanisms of susceptibility to oxidative lung injury in mice. Free Radic Biol Med 2007;42:433-45.
15. Asikainen TM, Huang T T, Taskinen E, et al. Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Free Radic Biol Med 2002;32:175-86.
16. Marzec JM, Christie JD, Reddy SP, et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007;21:2237-46.
17. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84-93.
18. Bentley AR, Emrani P, Cassano PA. Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Torax 2008;63:956-61.
19. Okano Y, Nezu U, Enokida Y, et al. SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women. PLoS One 2013;8:e73794.
20. Pietrzyk JJ, Kwinta P, Wollen EJ, et al. Gene expression profling in preterm infants: new aspects of bronchopulmonary dysplasia development. PLoS One 2013;8:e78585.
21. Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D. Rapid polyu-biquitination and proteasomal degradation of a mutant form of NAD(P) H:quinone oxidoreductase 1. Mol Pharmacol 2001;59:263-8.
22. Fagerholm R, Hofstetter B, Tommiska J, et al. NAD(P)H:quinone oxidore-ductase 1 NQO1∗2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet 2008;40:844-53.
23. Zai CC, Tiwari AK, Basile V, et al. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidore-ductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:50-6.
24. Lajin B, Alachkar A. Te NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer 2013;109:1325-37.
25. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 2005;7:463-78.
26. Reddy P, Naidoo RN, Robins TG, et al. GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren. Lung 2010;188:409-14.
27. Potts-Kant EN, Li Z, Tighe RM, et al. NAD(P)H:quinone oxidoreductase 1 protects lungs from oxidant-induced emphysema in mice. Free Radic Biol Med 2012;52:705-15.
28. Suzuki T, Shibata T, Takaya K, et al. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol Cell Biol 2013;33:2402-12.
29. Córdova EJ, Jiménez-Morales S, Centeno F, et al. NFE2L2 gene variants and susceptibility to childhood-onset asthma. Rev Invest Clin 2011;63:407-11.
30. Sandford AJ, Malhotra D, Boezen HM, et al. NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease. Physiol Genomics 2012;44:754-63.
31. Sutton A, Imbert A, Igoudjil A, et al. Te manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005;15:311-9.
32. Giusti B, Vestrini A, Poggi C, et al. Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants. Free Radic Res 2012;46:1130-9.
33. Zimniak P, Nanduri B, Pikuła S, et al. Naturally occurring human glutathi-one S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 difer in enzymic properties. Eur J Biochem 1994;224:893-9.
34. Koide S, Kugiyama K, Sugiyama S, et al. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomo-tor dysfunction and myocardial infarction. J Am Coll Cardiol 2003;41: 539-45.
35. Tang W, Bentley AR, Kritchevsky SB, et al.; Health ABC study. Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function. Free Radic Biol Med 2013;63:304-12.
36. Siedlinski M, Postma DS, van Diemen CC, Blokstra A, Smit HA, Boezen HM. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes. Am J Respir Crit Care Med 2008;178:13-9.
37. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996;15:9-19.
38. Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000;66:187-95.
39. Tanaka G, Aminuddin F, Akhabir L, et al. Efect of heme oxygenase-1 polymorphisms on lung function and gene expression. BMC Med Genet 2011;12:117.
40. Walsh M, Engle W, Laptook A, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics 2005;116:857-61.